Ariel Investments, LLC Gilead Sciences, Inc. Transaction History

Ariel Investments, LLC

$8.47 Billion
Q2 2024

A detailed history of Ariel Investments, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ariel Investments, LLC holds 368,411 shares of GILD stock, worth $32.4 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

368,411

Previous 742,900 50.41%

Holding current value

$32.4 Million

Previous $54.4 Million 53.55%

% of portfolio

0.3%

Previous 0.58%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $23.6 Million - $27.3 Million	-374,489 Reduced 50.41%	368,411 $25.3 Million
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $489,607 - $597,063	-6,840 Reduced 0.91%	742,900 $54.4 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $12.8 Million - $14.5 Million	-174,247 Reduced 18.86%	749,740 $60.7 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $15.9 Million - $17.4 Million	-215,344 Reduced 18.9%	923,987 $69.2 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $2.73 Million - $3.11 Million	-35,897 Reduced 3.05%	1,139,331 $87.8 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $272,285 - $310,217	-3,522 Reduced 0.3%	1,175,228 $97.5 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $93.2 Million - $134 Million	-1,495,360 Reduced 55.92%	1,178,750 $101 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $2.58 Million - $2.94 Million	-43,298 Reduced 1.59%	2,674,110 $165 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $4.53 Million - $5.1 Million	78,492 Added 2.97%	2,717,408 $168 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $13.1 Million - $16.4 Million	225,340 Added 9.34%	2,638,916 $157 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $13.4 Million - $15.2 Million	-206,320 Reduced 7.88%	2,413,576 $175 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $8.13 Million - $8.77 Million	120,097 Added 4.8%	2,619,896 $183 Million
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $21.2 Million - $23.2 Million	-334,544 Reduced 11.8%	2,499,799 $172 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $8.68 Million - $9.9 Million	-144,611 Reduced 4.85%	2,834,343 $183 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $21.3 Million - $24.2 Million	375,241 Added 14.41%	2,978,954 $174 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $46.6 Million - $58.7 Million	751,198 Added 40.55%	2,603,713 $165 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $58.9 Million - $68.4 Million	-813,720 Reduced 30.52%	1,852,515 $143 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $9.73 Million - $12.5 Million	155,417 Added 6.19%	2,666,235 $199 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $1.25 Million - $1.38 Million	20,292 Added 0.81%	2,510,818 $163 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $150,086 - $165,669	-2,401 Reduced 0.1%	2,490,526 $158 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $2.52 Million - $2.82 Million	40,695 Added 1.66%	2,492,927 $168 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $3.01 Million - $3.38 Million	48,183 Added 2.0%	2,452,232 $159 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $5.33 Million - $5.9 Million	74,789 Added 3.21%	2,404,049 $186 Million
Q2 2018 Aug 10, 2018	BUY	$64.88 - $75.68 $10.4 Million - $12.1 Million	159,941 Added 7.37%	2,329,260 $165 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $4.88 Million - $5.95 Million	-67,018 Reduced 3.0%	2,169,319 $164 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $4.76 Million - $5.59 Million	66,900 Added 3.08%	2,236,337 $160 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $5.67 Million - $6.72 Million	78,624 Added 3.76%	2,169,437 $176 Million
Q2 2017 Aug 14, 2017	BUY	N/A	2,090,813	2,090,813 $148 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ariel Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ariel Investments, LLC with notifications on news.

Account

Ariel Investments, LLC Gilead Sciences, Inc. Transaction History